Internal Medicine

3151 questions

Question 2921Question →

An 8181-year-old woman is brought to the emergency department from a skilled nursing facility due to the sudden onset of severe, unrelenting abdominal pain that began 44 hours ago. The facility staff reports that she has become progressively lethargic and confused over the past hour. Her past medical history is significant for heart failure with preserved ejection fraction, hypertension, and paroxysmal non-valvular atrial fibrillation. She has not taken her prescribed apixaban for the last three weeks due to an insurance coverage issue.

Her temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), pulse is 132/min132/\text{min} and irregularly irregular, blood pressure is 82/48 mmHg82/48\text{ mmHg}, and respirations are 26/min26/\text{min}. Pulse oximetry shows 94%94\% on ambient air. She is diaphoretic and writhing in bed. Cardiopulmonary examination reveals an irregular heartbeat with no murmurs, and the lungs are clear to auscultation. The abdomen is rigid and distended. There is diffuse, severe tenderness to palpation with marked involuntary guarding and rebound tenderness in all four quadrants. Bowel sounds are absent. Digital rectal examination yields grossly normal-appearing stool that is positive for occult blood.

Laboratory studies are as follows:

ParameterResultReference Range
Leukocyte count24,500/mm324,500/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Hemoglobin11.2 g/dL11.2\text{ g/dL}12.0−15.5 g/dL12.0-15.5\text{ g/dL}
Platelet count190,000/mm3190,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Serum sodium138 mEq/L138\text{ mEq/L}136−145 mEq/L136-145\text{ mEq/L}
Serum potassium5.1 mEq/L5.1\text{ mEq/L}3.5−5.0 mEq/L3.5-5.0\text{ mEq/L}
Serum chloride104 mEq/L104\text{ mEq/L}95−105 mEq/L95-105\text{ mEq/L}
Serum bicarbonate10 mEq/L10\text{ mEq/L}22−28 mEq/L22-28\text{ mEq/L}
Blood urea nitrogen42 mg/dL42\text{ mg/dL}8−20 mg/dL8-20\text{ mg/dL}
Serum creatinine1.8 mg/dL1.8\text{ mg/dL}0.6−1.2 mg/dL0.6-1.2\text{ mg/dL}
Serum lactate8.4 mmol/L8.4\text{ mmol/L}0.5−2.2 mmol/L0.5-2.2\text{ mmol/L}

Arterial blood gas analysis on room air shows a pH of 7.187.18 and a pCO2\text{pCO}_2 of 28 mmHg28\text{ mmHg}.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Immediate exploratory laparotomy

Answer

Immediate exploratory laparotomy is the correct management due to the presence of hemodynamic instability and overt peritonitis indicating transmural bowel infarction.
This patient presents with classic signs of acute mesenteric ischemia (AMI) resulting from an arterial embolus secondary to unanticoagulated atrial fibrillation. The sudden onset of unrelenting pain, profoundly elevated lactate, leukocytosis, and anion gap metabolic acidosis strongly support this diagnosis. Most critically, her physical examination demonstrates a rigid abdomen with marked rebound tenderness and involuntary guarding. These findings, combined with hemodynamic instability (hypotension, tachycardia), indicate that the affected bowel segment has progressed to transmural infarction and necrosis, leading to peritonitis. In any patient with an acute surgical abdomen and hemodynamic compromise, the definitive and immediate next step is exploratory laparotomy to resect the nonviable bowel and prevent further systemic toxicity. Delaying surgery for imaging or attempting purely medical management in this context is associated with near-universal mortality.

Step-by-Step Solution

1
Identify the underlying pathology based on the patient's history and symptoms.
The patient has a history of atrial fibrillation, is off anticoagulation, and presents with sudden, severe abdominal pain, pinpointing an embolic acute mesenteric ischemia.
Sudden pain out of proportion to exam findings in a patient with risk factors for arterial thromboembolism is classic for superior mesenteric artery (SMA) occlusion.
2
Assess the severity and stage of the ischemia.
The presence of hypotension, profound leukocytosis, severe lactic acidosis, and a rigid abdomen with rebound tenderness indicates advanced disease.
These findings signify that the ischemia has progressed to transmural bowel infarction, leading to loss of mucosal integrity, bacterial translocation, peritonitis, and septic shock.
3
Determine the definitive intervention based on the patient's clinical stability.
Immediate exploratory laparotomy must be performed.
When an acute surgical abdomen (peritonitis) or hemodynamic instability is present, imaging studies (like CT angiography) must be bypassed to prevent deadly delays in surgically resecting the necrotic bowel.

Key Concept

Patients with acute mesenteric ischemia who exhibit signs of peritonitis (e.g., rigid abdomen, rebound tenderness) or hemodynamic instability require immediate exploratory laparotomy, bypassing diagnostic imaging.
Question 2922Question →

An 82-year-old woman is evaluated in the hospital on the day of her planned discharge. She was admitted 4 days ago for an acute exacerbation of heart failure, which has now resolved with intravenous diuresis. An indwelling urinary catheter was placed on admission to closely monitor her urine output. Today, the nursing staff reports that her urine appears cloudy and has a strong malodorous scent. The patient feels well, has no new complaints, and is eager to return home. Her temperature is 37.1 C (98.8 F), blood pressure is 126/78 mm Hg, and pulse is 76/min. Physical examination reveals clear lungs, normal heart sounds, and no suprapubic or costovertebral angle tenderness. A urinalysis shows 15-20 white blood cells/hpf and positive nitrites. Urine culture from a sample taken from the catheter port grows >100,000 CFU/mL of Escherichia coli. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Remove the indwelling urinary catheter and observe

Answer

Remove the indwelling urinary catheter and observe the patient without initiating antimicrobial therapy.
This patient has asymptomatic bacteriuria (ASB). Patients with indwelling Foley catheters rapidly become colonized with bacteria, which frequently leads to cloudy or malodorous urine and positive nitrites, leukocyte esterase, and pyuria on urinalysis. However, in the absence of localizing symptoms (e.g., suprapubic pain, costovertebral angle tenderness) or systemic signs (e.g., fever, altered mental status, hemodynamic instability), these findings represent colonization rather than active infection. According to current guidelines, ASB should not be screened for or treated with antibiotics in this demographic. Since the patient's heart failure exacerbation has resolved and diuresis is complete, the catheter is no longer indicated. The most appropriate next step is simply to remove the catheter and observe the patient, allowing for her safe discharge.

Step-by-Step Solution

1
Evaluate the clinical presentation for signs of true urinary tract infection.
The patient has cloudy, malodorous urine and a positive culture, but lacks fever, suprapubic pain, costovertebral angle tenderness, and hemodynamic instability.
Cloudy or malodorous urine is common with indwelling catheters and does not independently define a symptomatic infection.
2
Determine the diagnosis based on current guidelines.
The presentation is consistent with asymptomatic bacteriuria (ASB) in a catheterized patient.
ASB is defined as the presence of bacteria in the urine without accompanying signs or symptoms attributable to a urinary tract infection.
3
Select the appropriate management strategy.
Discontinue the unnecessary urinary catheter and withhold antibiotics.
Antibiotic treatment for ASB is generally contraindicated as it does not improve outcomes and increases the risk of antimicrobial resistance. The catheter is no longer needed since diuresis is complete, so removal is the definitive next step.

Key Concept

Asymptomatic bacteriuria in patients with indwelling catheters should not be treated with antibiotics, even in the presence of pyuria, cloudy urine, or malodorous urine. Management involves removing the catheter if it is no longer indicated.
Estimated Time:1m 15s
Question 2923Question →

A 3232-year-old man is brought to the emergency department by paramedics following a generalized tonic-clonic seizure. His roommate witnessed the event, reporting that the seizure lasted for approximately 1010 minutes before stopping on its own. On arrival, the patient is deeply lethargic and only withdraws to painful stimuli. His temperature is 37.2∘C37.2^\circ C (99.0∘F99.0^\circ F), blood pressure is 118/76118/76 mmHgmmHg, pulse is 110/min110/min, and respiratory rate is 8/min8/min. Pulse oximetry shows 92%92\% on room air.

Laboratory results are as follows:
Sodium: 140140 mEq/LmEq/L
Potassium: 4.54.5 mEq/LmEq/L
Chloride: 100100 mEq/LmEq/L
Bicarbonate: 1212 mEq/LmEq/L
Blood urea nitrogen: 1616 mg/dLmg/dL
Serum creatinine: 1.21.2 mg/dLmg/dL

An arterial blood gas drawn on room air reveals:
pH: 7.157.15
pCO 2_2: 4040 mmHgmmHg
pO 2_2: 6565 mmHgmmHg

Which of the following best describes this patient's acid-base status?

Show answer & explanation

Answer: Mixed high anion-gap metabolic acidosis and respiratory acidosis

Answer

The correct answer is a mixed high anion-gap metabolic acidosis and respiratory acidosis.
This patient has an acidemia (pH=7.15pH = 7.15) driven by a low serum bicarbonate (1212 mEq/LmEq/L), establishing a primary metabolic acidosis. The anion gap is calculated as Na+−(Cl−+HCO3−)=140−(100+12)=28Na^+ - (Cl^- + HCO_3^-) = 140 - (100 + 12) = 28 mEq/LmEq/L. Because the normal anion gap is approximately 10−1410-14 mEq/LmEq/L, an anion gap of 2828 indicates a robust high anion-gap metabolic acidosis, likely secondary to profound lactic acidosis from the prolonged muscular exertion and transient hypoxia of the seizure. Next, respiratory compensation must be evaluated using Winter's formula: Expected pCO2=(1.5×[HCO3−])+8±2pCO_2 = (1.5 \times [HCO_3^-]) + 8 \pm 2. For this patient, the expected pCO2pCO_2 is (1.5×12)+8=26±2(1.5 \times 12) + 8 = 26 \pm 2 mmHgmmHg. The patient's actual pCO2pCO_2 on the arterial blood gas is 4040 mmHgmmHg. Because the measured pCO2pCO_2 is substantially higher than the expected range of 24−2824-28 mmHgmmHg, there is a concurrent primary respiratory acidosis. Clinically, this is consistent with post-ictal central nervous system depression causing hypoventilation, as evidenced by his low respiratory rate of 8/min8/min. Therefore, the patient has a mixed high anion-gap metabolic acidosis and respiratory acidosis.

Step-by-Step Solution

1
Analyze the pH and bicarbonate to determine the primary disorder.
The pH is 7.15 (acidemia) and the bicarbonate is 12 mEq/L (low), indicating a primary metabolic acidosis.
Establishing the initial acid-base disturbance directs the subsequent formulas and calculations needed.
2
Calculate the serum anion gap.
AG = 140 - (100 + 12) = 28 mEq/L. This indicates a high anion-gap metabolic acidosis (HAGMA).
Metabolic acidosis must always be classified into normal or high anion gap to narrow the differential diagnosis. Here, severe muscle contraction leads to lactic acidosis.
3
Calculate the expected respiratory compensation using Winter's formula.
Expected pCO2 = (1.5 × 12) + 8 ± 2 = 26 ± 2 mmHg. The expected range is 24 to 28 mmHg.
Metabolic acidosis stimulates central chemoreceptors to increase the respiratory rate, thereby blowing off CO2 to compensate for the acidemia.
4
Compare actual pCO2 to the expected pCO2.
The actual pCO2 of 40 mmHg is significantly higher than the expected range of 24-28 mmHg.
When the actual pCO2 is greater than the expected pCO2, it indicates a superimposed primary respiratory acidosis. This patient is post-ictal, causing central respiratory depression (respiratory rate of 8/min).

Key Concept

Patients with a primary metabolic acidosis should hyperventilate to reduce their pCO2. If the measured pCO2 is higher than the value predicted by Winter's formula, a concurrent respiratory acidosis is present.
Question 2924Question →

A 24-year-old primigravida at 28 weeks gestation presents to the obstetrical triage unit complaining of worsening shortness of breath and a cough that is occasionally productive of blood-streaked sputum. She immigrated to the United States two years ago and has had limited prior medical care. The patient notes that her breathing is significantly worse when she attempts to lie flat in bed. Temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 108/68 mmHg108/68\text{ mmHg}, pulse is 118/min118/\text{min} and regular, and respirations are 26/min26/\text{min}. Pulse oximetry (SpO2SpO_2) is 92%92\% on room air. Physical examination shows jugular venous distention. Lung auscultation reveals bilateral crackles in the lower lung fields. Cardiac auscultation in the left lateral decubitus position demonstrates a prominent first heart sound (S1S_1) and a low-pitched, mid-diastolic rumble at the apex. Which of the following is the most appropriate next step in patient care?

Show answer & explanation

Answer: Transthoracic echocardiography

Answer

Transthoracic echocardiography
The correct intervention is transthoracic echocardiography. This patient's presentation—orthopnea, hemoptysis, bibasilar crackles, a loud S1S_1, and a mid-diastolic rumble—is highly characteristic of mitral stenosis, likely due to rheumatic heart disease. The physiologic cardiovascular changes of pregnancy, specifically the expansion of plasma volume and the natural increase in maternal heart rate, significantly decrease diastolic filling time. In a patient with a fixed narrowed mitral valve, this leads to a rapid increase in left atrial pressure, which subsequently causes pulmonary venous congestion and acute pulmonary edema. An echocardiogram is the definitive next step to confirm the diagnosis, evaluate the valve morphology, measure the transmitral gradient, and guide further therapeutic measures (e.g., beta-blockers to increase diastolic filling time, or diuretics).

Step-by-Step Solution

1
Analyze the patient's vital signs and physical examination findings.
The patient exhibits tachycardia, tachypnea, hypoxia, orthopnea, a loud S1S_1, a mid-diastolic rumble, and bibasilar crackles.
Identifying these clinical signs points to a structural cardiac lesion leading to acute pulmonary edema.
2
Correlate the physical findings with the patient's pregnancy status and demographic background.
The diastolic rumble is characteristic of mitral stenosis, likely secondary to undiagnosed rheumatic heart disease given her immigration history. Pregnancy naturally increases blood volume and heart rate, which exacerbates the transmitral gradient and leads to decompensation.
Establishing the underlying pathophysiology explains why the condition has acutely worsened during the late second trimester.
3
Determine the most appropriate initial diagnostic intervention.
Transthoracic echocardiography is selected as the primary diagnostic tool.
Echocardiography is the non-invasive gold standard for diagnosing valvular heart disease, quantifying severity, and directing medical or procedural management.

Key Concept

Recognition of mitral stenosis exacerbation during pregnancy and appropriate diagnostic evaluation with echocardiography.
Estimated Time:1m 30s
Question 2925Question →

A 6464-year-old man comes to the clinic for a routine follow-up. He has a 1515-year history of type 2 diabetes mellitus, hypertension, and hyperlipidemia. His current medications include lisinopril, amlodipine, atorvastatin, and insulin glargine. Blood pressure is 138/86 mm Hg138/86 \text{ mm Hg}, and pulse is 76/min76\text{/min}. Physical examination reveals decreased sensation to monofilament testing in the bilateral feet. Laboratory studies show the following:

ParameterResult
Serum sodium139 mEq/L139 \text{ mEq/L}
Serum potassium5.6 mEq/L5.6 \text{ mEq/L}
Serum chloride109 mEq/L109 \text{ mEq/L}
Serum bicarbonate18 mEq/L18 \text{ mEq/L}
Blood urea nitrogen32 mg/dL32 \text{ mg/dL}
Serum creatinine1.9 mg/dL1.9 \text{ mg/dL}
Urine pH5.25.2

Which of the following is the most likely primary mechanism responsible for this patient's laboratory findings?

Show answer & explanation

Answer: Decreased production of and tubular responsiveness to aldosterone

Answer

Decreased production of and tubular responsiveness to aldosterone
The correct answer identifies the underlying pathophysiology of Type 4 Renal Tubular Acidosis (RTA). This patient presents with a metabolic acidosis (low bicarbonate of 18 mEq/L18 \text{ mEq/L}) and a normal anion gap of 12 mEq/L12 \text{ mEq/L}. The presence of hyperkalemia (5.6 mEq/L5.6 \text{ mEq/L}) in the setting of a normal anion gap metabolic acidosis points to a defect in aldosterone secretion or action (Type 4 RTA). In patients with long-standing diabetes, damage to the juxtaglomerular apparatus leads to a state of hyporeninemic hypoaldosteronism. Additionally, the patient is taking an ACE inhibitor (lisinopril), which further blunts aldosterone production. Without adequate aldosterone effect at the distal tubule, there is impaired secretion of both potassium and hydrogen ions, resulting in hyperkalemia and mild metabolic acidosis. The kidneys retain the ability to acidify the urine in Type 4 RTA, which is reflected in the appropriately low urine pH (5.25.2).

Step-by-Step Solution

1
Calculate the serum anion gap.
Anion Gap = Na+−(Cl−+HCO3−)=139−(109+18)=12 mEq/L\text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 139 - (109 + 18) = 12 \text{ mEq/L}.
Determining the anion gap is the first step in classifying any metabolic acidosis. A normal gap (8−12 mEq/L8-12 \text{ mEq/L}) narrows the differential to hyperchloremic metabolic acidosis (NAGMA).
2
Evaluate the serum potassium level in the context of NAGMA.
The patient has hyperkalemia (5.6 mEq/L5.6 \text{ mEq/L}).
In NAGMA, the potassium level helps differentiate the etiology. Hypokalemia suggests GI losses (diarrhea) or Type 1 / Type 2 RTA. Hyperkalemia strongly points to Type 4 RTA.
3
Synthesize the clinical context and remaining lab values.
The patient has a hyperkalemic NAGMA with an acidic urine (pH 5.25.2) in the setting of long-standing diabetes and ACE inhibitor use.
Diabetic nephropathy damages the juxtaglomerular apparatus, reducing renin and aldosterone. Lisinopril further inhibits aldosterone. The resulting hypoaldosteronism impairs distal potassium and hydrogen secretion, causing Type 4 RTA.

Key Concept

Diagnosis and pathophysiology of Type 4 Renal Tubular Acidosis (hyporeninemic hypoaldosteronism).
Question 2926Question →

A 68-year-old woman is brought to the emergency department by her family due to sudden-onset, severe shortness of breath that awoke her from sleep 2 hours ago. She reports feeling as though she is "drowning" and has a prominent cough producing frothy sputum. Her medical history is significant for long-standing bronchial asthma, poorly controlled essential hypertension, and osteoarthritis. Current medications include inhaled budesonide-formoterol, amlodipine, and diclofenac. Upon arrival, her blood pressure is 225/120 mm Hg, heart rate is 118/min, respiratory rate is 32/min, and oxygen saturation is 84% on room air. The patient is diaphoretic, sitting bolt upright, and using accessory muscles of respiration. Lung auscultation reveals diffuse, loud expiratory wheezing bilaterally with faint crackles at the lung bases. Cardiac examination is notable for regular tachycardia and an S4 gallop; an S3 gallop is not appreciated due to the loud breath sounds. A bedside point-of-care ultrasound reveals bilateral B-lines in all lung zones. Electrocardiogram shows sinus tachycardia and voltage criteria for left ventricular hypertrophy. Which of the following is the most appropriate initial pharmacological therapy for this patient?

Show answer & explanation

Answer: Intravenous nitroglycerin

Answer

The correct answer is intravenous nitroglycerin.
The correct answer is intravenous nitroglycerin. This patient's presentation is highly consistent with acute decompensated heart failure (ADHF) precipitating flash pulmonary edema, specifically characterized as sympathetic crashing acute pulmonary edema (SCAPE). Her extreme hypertension results in severely elevated afterload, which acutely impairs left ventricular forward flow and causes rapid fluid accumulation in the pulmonary alveoli and interstitium. The diffuse wheezing is a classic presentation of 'cardiac asthma', where peribronchial edema leads to airway narrowing, mimicking a primary asthma exacerbation. The presence of frothy sputum and bilateral B-lines on bedside ultrasound definitively points toward pulmonary edema rather than simple bronchospasm. Her recent use of diclofenac, an NSAID, likely contributed to fluid retention and worsening hypertension. The most appropriate initial pharmacological therapy is rapid afterload and preload reduction with intravenous vasodilators, such as nitroglycerin, often combined with non-invasive positive pressure ventilation (NIPPV).

Step-by-Step Solution

1
Analyze the patient's presentation and vital signs.
The patient has abrupt-onset severe dyspnea, extreme hypertension (225/120 mm Hg), hypoxia, frothy sputum, and diaphoresis.
Identifying these classic signs is critical to recognize a hypertensive emergency presenting as sympathetic crashing acute pulmonary edema.
2
Integrate physical examination and diagnostic findings.
Despite a history of asthma and the presence of diffuse wheezing, the B-lines on lung ultrasound and frothy sputum confirm the presence of extravascular lung water.
This differentiates primary respiratory failure (asthma exacerbation) from cardiogenic pulmonary edema, where peribronchial edema causes airway compression and secondary wheezing ('cardiac asthma').
3
Determine the most appropriate initial pharmacological therapy.
Intravenous nitroglycerin is selected to rapidly decrease both preload and afterload.
Rapid vasodilation relieves the extreme afterload on the failing left ventricle, shifting fluid out of the pulmonary circulation. Beta-blockers must be avoided due to negative inotropy.

Key Concept

Management of acute decompensated heart failure presenting as sympathetic crashing acute pulmonary edema (SCAPE).
Question 2927Question →

A hospital medicine team is evaluating a 65-year-old woman on the third day of her admission for acute cholangitis. On presentation to the hospital, she had a temperature of 39.2°C (102.6°F), pronounced scleral icterus, and right upper quadrant abdominal tenderness. Two sets of blood cultures were drawn, and empiric intravenous piperacillin-tazobactam was initiated. Later that same day, she underwent an uncomplicated endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy and successful extraction of a 1.5-cm common bile duct stone.

Today, the patient is clinically much improved. Her temperature is 37.1°C (98.8°F), her abdominal pain has entirely resolved, and her leukocyte count has decreased from 18,000/mm³ on admission to 8,500/mm³. The admission blood cultures are now growing *Escherichia coli* in both sets. The laboratory's antimicrobial susceptibility report indicates the isolate is resistant to ampicillin but susceptible to ceftriaxone, ciprofloxacin, meropenem, and piperacillin-tazobactam.

Which of the following is the most appropriate next step in pharmacotherapy for this patient?

Show answer & explanation

Answer: Change to intravenous ceftriaxone

Answer

Change to intravenous ceftriaxone
The correct answer is changing to intravenous ceftriaxone. This vignette describes a patient who presented with severe acute cholangitis and appropriately received source control (ERCP) and broad-spectrum empiric antibiotics (piperacillin-tazobactam). Now that the blood culture has resulted with a single pathogen (*E. coli*) and its susceptibility profile is known, the core principle of antimicrobial stewardship dictates de-escalation. De-escalation involves narrowing the antibiotic spectrum to target the specific organism identified. Piperacillin-tazobactam provides broad Gram-negative, anaerobic, and anti-pseudomonal coverage. Because the isolated *E. coli* is susceptible to ceftriaxone (a third-generation cephalosporin without anti-pseudomonal activity), switching to ceftriaxone provides adequate definitive coverage while minimizing collateral damage to the patient's microbiome and reducing the risk of resistant organism emergence.

Step-by-Step Solution

1
Evaluate the patient's clinical status and source control.
The patient is afebrile, asymptomatic, and has normalizing labs after a successful ERCP.
Confirms that the initial management was effective and the patient is stable enough to adjust medications.
2
Analyze the microbiological data.
Blood cultures confirm *E. coli* bacteremia susceptible to multiple agents, including ceftriaxone.
Guides the transition from empiric therapy to targeted therapy.
3
Apply the principles of antimicrobial stewardship.
Identify the antimicrobial with the narrowest spectrum that effectively covers the isolated pathogen.
Prevents the development of antimicrobial resistance and reduces the risk of adverse effects like Clostridioides difficile infection.
4
Select the appropriate targeted agent.
Ceftriaxone is chosen over continuing piperacillin-tazobactam.
Ceftriaxone adequately covers the susceptible *E. coli* without unnecessary anaerobic or anti-pseudomonal activity.

Key Concept

Antimicrobial de-escalation in acute cholangitis
Question 2928Question →

An internal medicine team evaluates a patient ready for transfer out of the acute care unit. The patient, a resident of an assisted living facility, presented 72 hours ago with profound chills, vomiting, and right-sided back pain. She was hemodynamically stable but highly symptomatic, prompting the initiation of empiric intravenous piperacillin-tazobactam. Currently, she has been afebrile for 24 hours, her vital signs are within normal limits, and she is comfortably eating a regular diet. Microbiological analysis of both blood and urine samples collected on admission reveals heavy growth (>105 CFU/mL>10^5 \text{ CFU/mL}) of *Enterococcus faecalis*. Susceptibility testing confirms the isolate is susceptible to ampicillin, amoxicillin, vancomycin, and nitrofurantoin. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Initiate oral amoxicillin therapy

Answer

The most appropriate step is to initiate oral amoxicillin therapy.
The correct answer is to initiate oral amoxicillin therapy. This patient presented with acute pyelonephritis complicated by bacteremia caused by *Enterococcus faecalis*. She is now clinically stable, afebrile, and tolerating oral intake, which are the core clinical criteria for stepping down from intravenous to oral antimicrobial therapy. *E. faecalis* is typically highly susceptible to aminopenicillins. Oral amoxicillin has excellent gastrointestinal absorption and achieves high therapeutic concentrations in both the bloodstream and the renal parenchyma. De-escalating from empiric broad-spectrum piperacillin-tazobactam to targeted oral amoxicillin demonstrates excellent antimicrobial stewardship while facilitating hospital discharge.

Step-by-Step Solution

1
Identify the patient's current clinical status and primary diagnosis.
The patient has acute pyelonephritis with associated bacteremia, but is now hemodynamically stable, afebrile, and successfully tolerating oral intake.
Determining clinical stability dictates whether empiric intravenous therapy can be safely transitioned to targeted oral therapy.
2
Analyze the microbiological data and susceptibility results.
Blood and urine cultures grew Enterococcus faecalis that is susceptible to ampicillin, amoxicillin, nitrofurantoin, and vancomycin.
Pathogen identification and in vitro susceptibility guide the selection of a definitive antimicrobial agent.
3
Rule out inappropriate agents based on pharmacokinetics.
Nitrofurantoin is rejected despite in vitro susceptibility.
Nitrofurantoin does not penetrate the renal parenchyma or bloodstream, making it ineffective and contraindicated for pyelonephritis and bacteremia.
4
Apply antimicrobial stewardship principles to select the optimal definitive therapy.
Oral amoxicillin is chosen as the final regimen.
Proper stewardship requires de-escalating to the narrowest effective agent. Amoxicillin targets the pathogen effectively, achieves high levels in the blood and renal tissue, and avoids the unnecessary use of broad-spectrum or intravenous agents.

Key Concept

Antimicrobial stewardship in Enterococcal bacteremia and pyelonephritis, specifically recognizing the pharmacokinetic limitations of nitrofurantoin.
Question 2929Question →

Match each characteristic urinalysis sediment finding with its most likely underlying renal pathology.

Click a left item, then click its matching right item

Items

Pigmented 'muddy brown' granular casts and epithelial cell casts
Dysmorphic red blood cells and red blood cell casts
White blood cell casts, sterile pyuria, and eosinophiluria
Fatty casts and oval fat bodies with a 'Maltese cross' appearance under polarized light

Matches

Show answer & explanation

Answer

The correct pairings link muddy brown casts to acute tubular necrosis, dysmorphic red blood cells to acute glomerulonephritis, white blood cell casts with eosinophiluria to acute interstitial nephritis, and fatty casts to nephrotic syndrome.
Each urinalysis sediment pattern reflects a distinct pathophysiological process in the kidney. Granular casts form from necrotic tubular cells (ATN). RBC casts form from glomerular bleeding (nephritic syndrome). WBC casts with eosinophils reflect interstitial allergic inflammation (AIN). Fatty casts reflect severe hyperlipidemia and lipiduria secondary to profound proteinuria (nephrotic syndrome).

Step-by-Step Solution

1
Analyze the urinalysis finding of 'muddy brown' granular casts.
Matches with Acute tubular necrosis.
These casts are formed from necrotic tubular epithelial cells sloughing into the tubular lumen due to ischemic or toxic injury.
2
Analyze the finding of dysmorphic red blood cells and red blood cell casts.
Matches with Acute glomerulonephritis.
Dysmorphic RBCs and casts signify bleeding of glomerular origin, which occurs when inflammation disrupts the glomerular basement membrane.
3
Analyze the finding of white blood cell casts, sterile pyuria, and eosinophiluria.
Matches with Acute interstitial nephritis.
WBC casts indicate inflammation in the kidney itself (unlike simple cystitis), and eosinophils strongly suggest an allergic hypersensitivity reaction in the interstitium.
4
Analyze the finding of fatty casts and oval fat bodies.
Matches with Nephrotic syndrome.
Significant lipiduria occurs alongside massive proteinuria due to altered glomerular permeability and compensatory hepatic lipid synthesis.

Key Concept

Correlation of urinalysis sediment findings with specific renal pathologies
Question 2930Question →

A 68-year-old man is brought to the emergency department by his son following two days of progressively worsening breathlessness. The patient describes a new onset of coughing that yields thick, yellowish mucus. He has a known history of severe chronic obstructive pulmonary disease (COPD), hypertension, and a myocardial infarction three years ago. His daily medications include an inhaled long-acting muscarinic antagonist, as-needed inhaled short-acting beta-agonists, and low-dose aspirin.

Vital signs show a temperature of 37.6°C (99.7°F), blood pressure of 145/88 mmHg, pulse of 112/min, and respirations of 26/min. Pulse oximetry reveals an oxygen saturation of 87% while breathing ambient air.

On physical examination, the patient appears visibly anxious and is using accessory muscles of respiration. Assessment of the neck shows a jugular venous pressure of 9 cm H2OH_2O. Auscultation of the chest reveals widespread expiratory wheezes and a significantly prolonged expiratory phase, with no audible crackles. Cardiac examination shows a regular rhythm with no murmurs. Trace pitting edema is noted in both lower extremities.

Laboratory analysis reveals:
Leukocyte count: 11,200/mm³
Thyroid-stimulating hormone (TSH): 0.2 μU/mL\mu U/mL (normal: 0.4–4.0 μU/mL\mu U/mL)
Free T4: 1.1 ng/dL (normal: 0.9–1.7 ng/dL)
Total T3: 55 ng/dL (normal: 80–200 ng/dL)

An arterial blood gas sample obtained on room air demonstrates the following values:
pH: 7.27
PaCO2PaCO_2: 65 mmHg
PaO2PaO_2: 54 mmHg
HCO3−HCO_3^-: 29 mEq/L

A portable chest radiograph displays hyperlucency of the lung fields and flattened hemidiaphragms, with no evidence of focal consolidation or vascular congestion.

Which of the following interventions is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Application of noninvasive positive-pressure ventilation

Answer

Application of noninvasive positive-pressure ventilation
The patient is experiencing a severe acute exacerbation of COPD complicated by acute-on-chronic respiratory acidosis. Noninvasive positive-pressure ventilation (NIPPV) is strongly indicated for patients with COPD exacerbations who present with a pH < 7.30 or PaCO2PaCO_2 > 45 mmHg along with significant respiratory distress. It improves oxygenation, decreases carbon dioxide retention, reduces the work of breathing, and lowers both the rate of endotracheal intubation and overall mortality.

Step-by-Step Solution

1
Analyze the clinical presentation and physical exam findings.
The patient has an acute exacerbation of COPD, characterized by increased dyspnea, purulent sputum, wheezing, and hyperinflated lungs on radiography without signs of left-sided pulmonary edema.
Differentiating between an acute COPD exacerbation and acute decompensated heart failure is crucial for determining the correct therapeutic pathway.
2
Interpret the arterial blood gas (ABG) results.
The ABG reveals an acute-on-chronic respiratory acidosis with a pH of 7.27, elevated PaCO2PaCO_2 (65 mmHg), and hypoxemia.
The severity of the acid-base disturbance guides the choice of respiratory support.
3
Determine the appropriate intervention based on the ABG and clinical status.
Noninvasive positive-pressure ventilation (NIPPV) is the standard of care intervention.
NIPPV is strongly indicated in COPD exacerbations presenting with respiratory acidosis (pH < 7.30) to decrease the work of breathing, correct hypercapnia, and avoid endotracheal intubation.

Key Concept

Management of acute COPD exacerbation with respiratory acidosis
Estimated Time:1m 30s
Question 2931Question →

A 32-year-old woman comes to the clinic reporting a 5-month history of worsening fatigue, generalized weakness, and a 5-kg5\text{-kg} (11-lb11\text{-lb}) weight gain. She also notes new-onset cold intolerance and states she has not had a menstrual period since the birth of her second child 1414 months ago. Her delivery was complicated by severe uterine atony requiring emergency blood transfusions. Blood pressure is 92/58 mm Hg92/58\text{ mm Hg} and pulse is 56/min56\text{/min}. Physical examination reveals pale, dry skin, delayed relaxation of deep tendon reflexes, and diminished pubic and axillary hair.

Laboratory studies show:
Thyroid-stimulating hormone (TSH): 1.5 \muU/mL1.5\text{ \mu U/mL} (normal: 0.4−4.0 \muU/mL0.4-4.0\text{ \mu U/mL})
Free thyroxine (T4): 0.5 ng/dL0.5\text{ ng/dL} (normal: 0.9−1.7 ng/dL0.9-1.7\text{ ng/dL})

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Measurement of serum cortisol and adrenocorticotropic hormone

Answer

Measurement of serum cortisol and adrenocorticotropic hormone
This patient's presentation of fatigue, amenorrhea, and loss of pubic and axillary hair following severe postpartum hemorrhage is highly characteristic of Sheehan syndrome (postpartum ischemic necrosis of the pituitary gland). This condition leads to panhypopituitarism, characterized by deficiencies in multiple anterior pituitary hormones. Her laboratory results show a low free T4 with an inappropriately normal TSH, which confirms central (secondary) hypothyroidism. When central hypothyroidism is diagnosed, it is imperative to evaluate the hypothalamic-pituitary-adrenal (HPA) axis before initiating thyroid hormone replacement. Thyroid hormone increases the basal metabolic rate and accelerates the hepatic clearance of cortisol. In a patient with unrecognized and untreated central adrenal insufficiency, starting levothyroxine can precipitate a life-threatening acute adrenal crisis. Therefore, measuring serum cortisol and adrenocorticotropic hormone (ACTH) levels is the critical next step. If adrenal insufficiency is confirmed, glucocorticoid replacement must be initiated before or concurrently with levothyroxine.

Step-by-Step Solution

1
Interpret the clinical presentation and obstetric history.
The patient has signs of panhypopituitarism (amenorrhea, loss of axillary/pubic hair, fatigue) following a complicated delivery with severe hemorrhage.
Severe postpartum hemorrhage can cause ischemic necrosis of the pituitary gland (Sheehan syndrome).
2
Analyze the thyroid function tests.
Low free T4 with an inappropriately normal TSH confirms central (secondary) hypothyroidism.
In primary hypothyroidism, the low T4 would eliminate negative feedback, resulting in an elevated TSH. A normal or low TSH indicates pituitary dysfunction.
3
Determine the necessary safety sequence for management.
The hypothalamic-pituitary-adrenal axis must be evaluated before treating the central hypothyroidism.
Thyroid hormone replacement increases the metabolic clearance of cortisol. If given to a patient with underlying central adrenal insufficiency, it can trigger a fatal adrenal crisis.

Key Concept

In patients with central hypothyroidism or panhypopituitarism, adrenal insufficiency must be evaluated and treated with glucocorticoids before initiating levothyroxine therapy to prevent an acute adrenal crisis.
Question 2932Question →

A gastroenterology clinic regularly screens and evaluates patients for viral hepatitis. Proper interpretation of Hepatitis B serologic panels is critical for determining the phase of infection and appropriate management. Match each of the following patient Hepatitis B serologic profiles with the most appropriate clinical interpretation.

Click a left item, then click its matching right item

Items

Profile A: HBsAg (+), Anti-HBc IgM (+), HBeAg (+), Anti-HBs (-)
Profile B: HBsAg (-), Anti-HBc IgG (+), HBeAg (-), Anti-HBs (+)
Profile C: HBsAg (-), Anti-HBc (-), HBeAg (-), Anti-HBs (+)
Profile D: HBsAg (+), Anti-HBc IgG (+), HBeAg (-), Anti-HBs (-)

Matches

Show answer & explanation

Answer

Profile A corresponds to acute hepatitis B infection (highly infectious); Profile B corresponds to resolved prior infection (natural immunity); Profile C corresponds to immunity from vaccination; Profile D corresponds to chronic hepatitis B infection (inactive carrier state).
Matching each Hepatitis B serology profile to its correct clinical state relies on evaluating the presence of specific antigens and antibodies. HBsAg indicates active infection. Anti-HBc distinguishes natural exposure (positive) from vaccination (negative), with IgM marking acute disease and IgG marking chronic or past disease. Anti-HBs represents protective immunity, and HBeAg signifies high viral replication and infectivity.

Step-by-Step Solution

1
Evaluate the HBsAg (Surface Antigen) status.
Determines if the patient currently has the virus in their blood.
HBsAg is the primary hallmark of an active infection, whether in the acute or chronic phase.
2
Evaluate the Anti-HBc (Core Antibody) status and subtype (IgM vs. IgG).
Differentiates between acute infection (IgM), chronic or resolved infection (IgG), and vaccination (negative).
The core antigen is not present in the standard Hepatitis B vaccine, meaning Anti-HBc only develops after exposure to the natural virus.
3
Evaluate the Anti-HBs (Surface Antibody) status.
Determines if the patient has successfully achieved immunity.
Anti-HBs develops only after successful clearance of a natural infection or as an intended immune response to vaccination.
4
Evaluate the HBeAg (Envelope Antigen) status.
Determines the level of active viral replication and degree of infectivity.
HBeAg is a surrogate marker for active viral replication; its presence indicates a highly infectious state, whereas its absence in a chronic carrier points toward lower infectivity.

Key Concept

Interpretation of Hepatitis B serologic markers to determine infection phase and immunity status.
Question 2933Question →

A 71-year-old man is brought to the emergency department by his wife due to sudden-onset severe shortness of breath that awoke him from sleep. He reports feeling as though he is suffocating and has coughed up pink-tinged, frothy sputum. His past medical history is significant for a myocardial infarction 3 years ago, essential hypertension, and a 45-pack-year smoking history. Upon arrival, his temperature is 37.0°C (98.6°F), blood pressure is 180/105 mmHg, pulse is 118/min, and respirations are 32/min. Oxygen saturation is 84% on room air. He is diaphoretic and sitting upright, leaning forward. Lung auscultation reveals diffuse expiratory wheezing and bilateral crackles extending to the mid-lung fields. Cardiac auscultation demonstrates a regular tachycardia with a prominent S3 gallop. An arterial blood gas on room air shows:

pHpH: 7.22
PaCO2PaCO_2: 65 mmHg
PaO2PaO_2: 50 mmHg
HCO3−HCO_3^-: 26 mEq/L

Which of the following is the most appropriate initial pharmacologic intervention for this patient?

Show answer & explanation

Answer: Intravenous furosemide

Answer

The most appropriate initial pharmacologic intervention is intravenous furosemide to treat acute decompensated heart failure.
Intravenous furosemide is the correct choice because the patient's presentation of paroxysmal nocturnal dyspnea, pink-tinged frothy sputum, bilateral crackles, and an S3 gallop are classic for acute decompensated heart failure (ADHF) leading to cardiogenic pulmonary edema. The prominent wheezing is a phenomenon known as 'cardiac asthma,' caused by peribronchial edema restricting the airways. In the acute setting, intravenous loop diuretics (along with oxygen support and potentially vasodilators like nitroglycerin, given his severe hypertension) are the primary pharmacologic therapy to reduce volume overload and left ventricular preload.

Step-by-Step Solution

1
Analyze the patient's history and presenting symptoms.
The patient has sudden-onset paroxysmal nocturnal dyspnea, frothy pink sputum, and a history of myocardial infarction.
To establish the primary clinical syndrome and identify risk factors.
2
Interpret the physical examination findings.
Severe hypertension, tachypnea, hypoxia, diffuse wheezing, bilateral crackles, and an S3 gallop are present.
To differentiate between respiratory (e.g., COPD exacerbation) and cardiac etiologies of the patient's dyspnea.
3
Evaluate the arterial blood gas results.
The ABG shows an acute, uncompensated respiratory acidosis (pHpH 7.22, PaCO2PaCO_2 65 mmHg, normal HCO3−HCO_3^-).
To assess the severity of respiratory failure and rule out primary metabolic derangements.
4
Formulate a diagnosis and select the appropriate initial pharmacologic therapy.
The diagnosis is acute decompensated heart failure (ADHF) presenting as 'cardiac asthma'. The most appropriate pharmacologic treatment is intravenous furosemide.
Loop diuretics reduce intravascular volume and preload, which rapidly relieves pulmonary congestion.

Key Concept

Acute decompensated heart failure can present with prominent wheezing ('cardiac asthma') due to peribronchial edema. It is distinguished from COPD exacerbations by signs of left ventricular failure, such as an S3 gallop, pink frothy sputum, and bilateral crackles, and is treated initially with loop diuretics, vasodilators, and noninvasive ventilation.
Estimated Time:1m 30s
Question 2934Question →

Match the following classic electrocardiographic (ECG) findings with their most likely underlying structural or electrophysiologic pathology.

Click a left item, then click its matching right item

Items

Diffuse ST-segment elevations with reciprocal ST depression in leads aVR and V1, accompanied by PR-segment depression
Electrical alternans characterized by varying amplitudes of the QRS complex from beat to beat
Progressive lengthening of the PR interval culminating in a non-conducted P wave and a dropped QRS complex
Shortened PR interval, widened QRS complex, and a slurred initial upstroke of the QRS complex

Matches

Show answer & explanation

Answer

Diffuse ST elevations pair with inflammation of the fibroserous sac (acute pericarditis). Electrical alternans pairs with fluid accumulation causing pendular motion (cardiac tamponade). Progressive PR lengthening pairs with reversible atrioventricular node block (Mobitz Type I). A shortened PR interval with a slurred upstroke pairs with an accessory electrical pathway (Wolff-Parkinson-White syndrome).
Each classic ECG finding reliably reflects a specific structural or electrophysiological disruption. Epicardial inflammation causes diffuse repolarization abnormalities. Massive pericardial fluid creates a mechanical swinging effect altering ECG voltages. AV node disease causes progressive conduction delay. Finally, an accessory pathway creates a secondary, faster route for ventricular depolarization.

Step-by-Step Solution

1
Analyze the first ECG finding: Diffuse ST elevations and PR depressions.
Identified as the pathognomonic pattern for acute pericarditis.
Widespread ST elevation without corresponding vascular territory localizing signs indicates diffuse epicardial injury from sac inflammation.
2
Analyze the second ECG finding: Electrical alternans.
Identified as a classic sign of cardiac tamponade.
The varying height of the QRS complex is a mechanical artifact created by the heart swinging closer to and further from the chest wall leads within a massive pericardial effusion.
3
Analyze the third ECG finding: Progressive PR prolongation leading to a dropped beat.
Identified as Mobitz Type I (Wenckebach) second-degree heart block.
This pattern reflects progressive fatigue and delayed conduction, which anatomically occurs at the AV node.
4
Analyze the fourth ECG finding: Short PR interval with a delta wave.
Identified as ventricular pre-excitation (Wolff-Parkinson-White syndrome).
Electrical signals bypass the AV node's normal delay via an accessory pathway, exciting the ventricles early and causing the wide, slurred QRS complex.

Key Concept

Correlation of pathognomonic electrocardiographic findings with their specific underlying cardiovascular pathophysiology.
Question 2935Question →

A genetics consultation service is reviewing several patient charts for familial endocrine disorders. Based on the clinical descriptions provided below, match each patient's presentation with the most likely underlying genetic syndrome.

Click a left item, then click its matching right item

Items

A 28-year-old with recurrent calcium oxalate nephrolithiasis, refractory peptic ulcer disease, and bilateral temporal hemianopia.
A 35-year-old with episodic diaphoresis and tachycardia, elevated serum calcium, and a calcitonin-secreting thyroid nodule.
A 19-year-old with a tall and slender build, painless submucosal nodules on the lips and tongue, and severe paroxysmal hypertension.
A 12-year-old with chronic oral candidiasis, a positive Chvostek sign, and new-onset postural hypotension with generalized hyperpigmentation.

Matches

Show answer & explanation

Answer

Patient 1 matches with MEN 1; Patient 2 matches with MEN 2A; Patient 3 matches with MEN 2B; Patient 4 matches with Autoimmune polyendocrine syndrome type 1.
Each syndrome presents with a specific triad or cluster of clinical features. MEN 1 features parathyroid, pancreatic, and pituitary tumors. MEN 2A features medullary thyroid cancer, pheochromocytoma, and parathyroid hyperplasia. MEN 2B features medullary thyroid cancer, pheochromocytoma, mucosal neuromas, and marfanoid habitus. APS-1 features chronic mucocutaneous candidiasis, hypoparathyroidism, and Addison disease.

Step-by-Step Solution

1
Analyze Patient 1's symptoms of nephrolithiasis, peptic ulcer disease, and temporal hemianopia.
Identified as primary hyperparathyroidism, a gastrinoma, and a pituitary adenoma.
These three pathologies define the '3 Ps' (Parathyroid, Pancreas, Pituitary) of Multiple endocrine neoplasia type 1.
2
Evaluate Patient 2's symptoms of episodic tachycardia, hypercalcemia, and an elevated calcitonin level.
Identified as a pheochromocytoma, primary hyperparathyroidism, and medullary thyroid cancer.
This combination exactly matches the clinical triad of Multiple endocrine neoplasia type 2A.
3
Assess Patient 3's tall build, mucosal nodules, and paroxysmal hypertension.
Identified as marfanoid habitus, mucosal neuromas, and a pheochromocytoma.
These physical and clinical findings uniquely indicate Multiple endocrine neoplasia type 2B.
4
Review Patient 4's fungal infections, positive Chvostek sign, and hyperpigmentation.
Identified as chronic candidiasis, hypoparathyroidism, and primary adrenal insufficiency.
Recognizing this classic autoimmune destruction sequence points directly to Autoimmune polyendocrine syndrome type 1 (APS-1).

Key Concept

Clinical recognition of multiple endocrine neoplasia (MEN) syndromes and autoimmune polyendocrine syndromes based on combinations of distinct endocrine tumors and autoimmune diseases.
Estimated Time:1m 30s
Question 2936Question →

A 55-year-old man with a history of decompensated alcohol-related cirrhosis is evaluated on hospital day 3. He initially presented to the emergency department with a temperature of 38.2°C (100.8°F), diffuse abdominal pain, and worsening lethargy. A diagnostic paracentesis performed on admission yielded ascitic fluid with a neutrophil count of 650/mm3650/\text{mm}^3. Due to a history of multiple recent hospitalizations, he was empirically started on intravenous meropenem. Today, his mental status has returned to baseline, his abdominal pain has markedly improved, and he is afebrile. Ascitic fluid cultures obtained on admission have finalized, growing *Escherichia coli*. Susceptibility testing indicates the organism is susceptible to cefotaxime, ceftriaxone, and ciprofloxacin, but resistant to trimethoprim-sulfamethoxazole. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: De-escalate therapy to intravenous cefotaxime

Answer

De-escalate therapy to a narrower-spectrum agent, such as intravenous cefotaxime.
The correct answer highlights the core principle of antimicrobial stewardship: de-escalation. The patient was appropriately started on empiric meropenem given his recent hospitalizations (which increases the risk for multi-drug resistant organisms). However, now that ascitic fluid cultures have isolated an *Escherichia coli* strain that is susceptible to narrower-spectrum agents (like cefotaxime or ceftriaxone), maintaining carbapenem therapy is no longer justified. De-escalating to intravenous cefotaxime effectively treats the spontaneous bacterial peritonitis while minimizing the risk of developing carbapenem resistance and antibiotic-associated complications such as *Clostridioides difficile* infection.

Step-by-Step Solution

1
Diagnose the primary condition and evaluate the patient's clinical trajectory.
The patient has spontaneous bacterial peritonitis (SBP) and is showing clinical improvement on empiric broad-spectrum antibiotics (meropenem).
Establishing the baseline response confirms that the current therapy is working, but safety and resistance profiles must now be optimized.
2
Analyze the ascitic fluid culture and susceptibility results.
The culture grew E. coli susceptible to third-generation cephalosporins (cefotaxime, ceftriaxone) and ciprofloxacin.
Culture data allows for the transition from empiric 'best-guess' therapy to definitive, pathogen-directed therapy.
3
Apply the principles of antimicrobial stewardship.
Therapy is de-escalated from a carbapenem (meropenem) to a third-generation cephalosporin (cefotaxime).
Meropenem is an ultra-broad-spectrum antibiotic reserved for highly resistant organisms. Using it when a narrower agent is proven effective promotes the development of multidrug-resistant organisms.

Key Concept

In the management of spontaneous bacterial peritonitis, once culture and sensitivity results confirm an organism is susceptible to a narrower-spectrum antibiotic, empiric broad-spectrum therapy should be de-escalated to prevent antimicrobial resistance.

Alternative Method

Intravenous ceftriaxone could also be chosen for de-escalation, as it is another third-generation cephalosporin to which the organism is susceptible and is heavily utilized for SBP.
Estimated Time:1m 15s
Question 2937Question →

During morning rounds in the intensive care unit, the medical team evaluates a patient who was intubated seven days ago for airway protection following a subarachnoid hemorrhage. The patient has developed a new fever of 38.9∘C38.9^\circ \text{C} (102.0∘F102.0^\circ \text{F}) and thick, purulent endotracheal secretions. His oxygenation has deteriorated, requiring an increase in fractional inspired oxygen (FiO2\text{FiO}_2) from 0.300.30 to 0.550.55. Morning laboratory results show a leukocyte count of 18,500/mm318,500/\text{mm}^3. A bedside chest radiograph confirms a new lobar infiltrate in the left lung base. Suspecting a nosocomial respiratory infection, the team prepares to intervene. Arrange the following steps in the optimal chronological sequence for managing this patient's suspected complication.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The optimal sequence is: (1) Secure a respiratory specimen for culture, (2) Administer broad-spectrum empiric antibiotics, (3) Evaluate clinical trajectory and preliminary cultures at 48-72 hours, and (4) Transition to narrower-spectrum targeted therapy based on final susceptibilities.
The standard of care for suspected ventilator-associated pneumonia requires obtaining a microbiological sample (endotracheal aspirate or bronchoalveolar lavage) as the first intervention, provided it does not delay life-saving care. Immediately following the culture, broad-spectrum empiric antibiotics targeting nosocomial pathogens like MRSA and Pseudomonas must be started. Once 48 to 72 hours have elapsed, clinical response and preliminary culture data are utilized to assess treatment efficacy. Finally, when comprehensive susceptibility results return, broad-spectrum empiric therapy is de-escalated to narrow-spectrum agents to practice effective antibiotic stewardship.

Step-by-Step Solution

1
Recognize the clinical syndrome.
The patient meets the criteria for suspected ventilator-associated pneumonia (new infiltrate, fever, purulent secretions, worsening oxygenation after >48 hours of mechanical ventilation).
Identifying the complication dictates the subsequent infectious disease and critical care management algorithm.
2
Prioritize diagnostic sampling.
Lower respiratory tract cultures must be obtained via endotracheal aspirate or bronchoalveolar lavage.
Acquiring cultures before introducing new antimicrobial agents maximizes the chance of successfully isolating the offending pathogen.
3
Initiate emergent therapeutic intervention.
Empiric broad-spectrum antibiotics covering methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are administered.
Critically ill patients with hospital-acquired infections face high mortality rates if appropriate therapy is delayed; empiric coverage must address likely resistant nosocomial organisms.
4
Perform algorithmic clinical reassessment and stewardship.
At 48-72 hours, the patient's clinical status and culture results are evaluated to safely de-escalate to narrow-spectrum therapy.
This timeline aligns with the availability of culture growth data, allowing the critical care team to apply antibiotic stewardship principles and minimize resistance.

Key Concept

Ventilator-associated pneumonia (VAP) management requires securing lower respiratory tract cultures prior to the prompt initiation of empiric broad-spectrum antibiotics, followed by a formal reassessment at 48-72 hours to de-escalate therapy based on susceptibility data.

Alternative Method

In patients who are rapidly deteriorating or in profound septic shock, if obtaining a lower respiratory sample will cause an unacceptable delay (e.g., due to lack of immediate staff or equipment), antibiotics should be given immediately rather than waiting for the culture. However, in standard sequential management, culturing first remains the firm protocol.
Estimated Time:1m 0s
Question 2938Question →

An emergency medical services team brings a 7373-year-old man to the acute care bay with severe respiratory distress that began abruptly two hours ago. The patient is visibly agitated, diaphoretic, and cannot speak in full sentences. His wife reports that he has a history of essential hypertension, osteoarthritis, a 4040-pack-year smoking habit, and treatment-resistant depression for which a new medication (phenelzine) was initiated three weeks ago.

Vital signs:
Temperature: 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F})
Blood pressure: 192/108 mm Hg192/108\text{ mm Hg}
Heart rate: 118/min118\text{/min}
Respiratory rate: 28/min28\text{/min}
Oxygen saturation: 86%86\% on room air

Physical examination reveals prominent jugular venous distention. Lung auscultation yields diffuse, high-pitched expiratory wheezing bilaterally with prolonged expiratory phases. Cardiac examination reveals a regular tachycardia with a prominent extra heart sound heard just after S2\text{S}_2 at the cardiac apex. The abdomen is distended with a palpable liver edge 4 cm4\text{ cm} below the right costal margin.

Arterial blood gas analysis on room air shows:
pH\text{pH}: 7.497.49
pCO2\text{pCO}_2: 29 mm Hg29\text{ mm Hg}
pO2\text{pO}_2: 54 mm Hg54\text{ mm Hg}
HCO3−\text{HCO}_3^-: 22 mEq/L22\text{ mEq/L}

Chest radiography reveals bilateral perihilar opacities and blunting of the costophrenic angles.

Which of the following is the most appropriate initial pharmacological intervention for this patient?

Show answer & explanation

Answer: Intravenous furosemide

Answer

Intravenous furosemide
The correct intervention is Intravenous furosemide. This patient is presenting with acute decompensated heart failure (ADHF). Despite the heavy smoking history and prominent wheezing, the clinical picture is dominated by signs of profound fluid overload: jugular venous distention, a prominent S3 gallop, hepatomegaly, and radiographic evidence of pulmonary edema (perihilar opacities and pleural effusions). The wheezing in this scenario represents 'cardiac asthma,' a phenomenon where peribronchial interstitial edema compresses the small airways and causes expiratory wheezing that mimics primary airway disease. The immediate management of ADHF with pulmonary edema involves preload reduction and diuresis; therefore, intravenous loop diuretics (such as furosemide) are the most appropriate initial step.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and physical examination findings.
The patient has severe dyspnea, hypertension, jugular venous distention, an S3 gallop, hepatomegaly, and bilateral wheezing.
Identifying the cluster of symptoms is crucial to differentiate between pulmonary and cardiac etiologies of acute respiratory distress.
2
Interpret the diagnostic data (ABG and Chest X-ray).
The ABG shows acute respiratory alkalosis secondary to hypoxemia. The chest X-ray shows perihilar opacities and pleural effusions (blunted costophrenic angles).
The combination of an S3 gallop, right-sided heart failure signs, and radiographic evidence of pulmonary edema confirms a diagnosis of acute decompensated heart failure (ADHF).
3
Determine the cause of the wheezing in this specific context.
The wheezing is 'cardiac asthma' caused by peribronchial interstitial edema narrowing the airways, mimicking a primary reactive airway disease.
Recognizing cardiac asthma prevents the misdiagnosis of a COPD exacerbation.
4
Select the most appropriate initial pharmacological therapy for the confirmed diagnosis.
Intravenous furosemide is selected to reduce intravascular volume, decrease cardiac preload, and relieve pulmonary congestion.
Loop diuretics are the first-line therapy for volume-overloaded patients presenting with ADHF.

Key Concept

Acute decompensated heart failure can present with prominent wheezing ('cardiac asthma') due to peribronchial edema, which must be differentiated from COPD exacerbations using clinical signs like an S3 gallop and JVD to guide appropriate diuretic therapy.
Question 2939Question →

A 6868-year-old woman is admitted to the hospital with a 4848-hour history of colicky abdominal pain, severe nausea, and repeated episodes of bilious vomiting. She has not passed flatus or had a bowel movement for 33 days. Her past surgical history is significant for an open hysterectomy performed 1010 years ago. On initial evaluation, she was afebrile and hemodynamically stable. Her abdomen was distended and tympanic, with mild diffuse tenderness but no guarding or rebound. An initial plain abdominal radiograph demonstrated multiple dilated loops of small bowel with prominent air-fluid levels and a paucity of gas in the colon. She was admitted for conservative management with intravenous fluid resuscitation, bowel rest, and nasogastric tube decompression.

Twelve hours after admission, the patient reports a sudden worsening of her abdominal pain, which is now constant and severe. Her temperature is 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure is 92/58 mmHg92/58 \text{ mmHg}, pulse is 122/min122/\text{min}, and respiratory rate is 22/min22/\text{min}. Physical examination now reveals a rigid abdomen with marked diffuse tenderness, involuntary guarding, and rebound tenderness. Bowel sounds are absent. Laboratory studies demonstrate a leukocyte count of 22,000/mm322,000/\text{mm}^3 with a left shift, and a serum lactate level of 4.2 mmol/L4.2 \text{ mmol/L}.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Emergency exploratory laparotomy

Answer

Emergency exploratory laparotomy
The correct approach recognizes that the patient has transitioned from an uncomplicated small bowel obstruction to a strangulated small bowel obstruction, complicated by ischemia and imminent or actual perforation. This is evidenced by the shift from intermittent, colicky pain to constant, severe pain, accompanied by new-onset fever, tachycardia, hypotension, rigid abdomen (peritonitis), marked leukocytosis, and elevated serum lactate. In the setting of an acute surgical abdomen with hemodynamic compromise, definitive source control is urgently required. Emergent surgical exploration allows the surgeon to relieve the obstruction, assess bowel viability, and resect any necrotic segments.

Step-by-Step Solution

1
Analyze the initial presentation
The patient initially presented with an uncomplicated partial small bowel obstruction likely due to postoperative adhesions, which was appropriately managed with a trial of conservative therapy (nasogastric tube, intravenous fluids).
Establishing the baseline helps track clinical trajectory.
2
Evaluate the clinical changes at 12 hours
The patient developed a high fever (39.1∘C39.1^\circ\text{C}), tachycardia, hypotension, constant severe pain, a rigid abdomen with rebound tenderness (peritonitis), marked leukocytosis, and elevated lactate.
These findings represent a drastic deviation from an uncomplicated clinical course.
3
Determine the pathophysiologic mechanism of the deterioration
The transition from colicky pain to constant severe pain, along with peritonitis and lactic acidosis, strongly indicates that the obstructed bowel segment has become strangulated, leading to ischemia, necrosis, and potential perforation.
Identifying strangulation changes the management entirely.
4
Select the definitive management
An acute surgical abdomen with hemodynamic instability and suspected bowel necrosis dictates immediate operative intervention (exploratory laparotomy).
Surgical resection of ischemic bowel is necessary to prevent overwhelming sepsis and death; medical management or further imaging will fatally delay source control.

Key Concept

Patients with a small bowel obstruction who develop signs of strangulation or ischemia—such as fever, tachycardia, continuous severe pain, peritonitis, leukocytosis, or lactic acidosis—require immediate exploratory laparotomy.
Question 2940Question →

A 64-year-old man is evaluated on hospital day 4 for ongoing management of vertebral osteomyelitis. He initially presented with severe mid-back pain, fever, and focal spinal tenderness. Magnetic resonance imaging of the thoracic spine at admission demonstrated T8-T9 discitis and adjacent vertebral body osteomyelitis without an epidural abscess. Blood cultures drawn prior to antibiotic administration have now finalized, showing heavy growth of *Streptococcus agalactiae*. Susceptibility testing indicates the organism is sensitive to penicillin, ceftriaxone, cefepime, and vancomycin. He was empirically started on intravenous vancomycin and piperacillin-tazobactam. Currently, his temperature is 37.1°C (98.8°F), blood pressure is 128/82 mmHg, and pulse is 78/min. His back pain has improved, and his neurologic examination remains unremarkable. Which of the following is the most appropriate next step in pharmacotherapy?

Show answer & explanation

Answer: Discontinue current agents and initiate intravenous penicillin G

Answer

Discontinue current agents and initiate intravenous penicillin G
The correct answer involves discontinuing the broad-spectrum empiric regimen and initiating intravenous penicillin G. This patient has vertebral osteomyelitis caused by Streptococcus agalactiae (Group B Strep). Once the pathogen is identified and shown to be highly susceptible to penicillin, the standard of care—and the core principle of antimicrobial stewardship—is to de-escalate therapy to the narrowest effective agent. Intravenous penicillin G (or intravenous ceftriaxone) provides excellent, targeted bactericidal activity without unnecessarily altering gut flora or promoting broad-spectrum resistance. Because this is a deep-seated bone infection, an extended course of intravenous therapy (e.g., 4 to 6 weeks) is required.

Step-by-Step Solution

1
Analyze the patient's clinical status and microbiological data.
The patient has vertebral osteomyelitis caused by Streptococcus agalactiae, which is susceptible to multiple antibiotics including narrow-spectrum options like penicillin.
Establishing the exact pathogen and its sensitivity profile is the prerequisite for tailoring antibiotic therapy.
2
Evaluate the current empiric antibiotic regimen.
The patient is receiving intravenous vancomycin and piperacillin-tazobactam, which is an appropriately broad empiric regimen for suspected severe healthcare-associated or deep-seated infections.
Empiric therapy is designed to cover all likely pathogens until culture data returns.
3
Apply the principles of antibiotic stewardship to optimize therapy.
The regimen must be de-escalated from broad-spectrum coverage to the narrowest effective targeted therapy (intravenous penicillin G).
De-escalation minimizes collateral damage to the microbiome, reduces the development of antimicrobial resistance, and limits drug toxicity.

Key Concept

Antibiotic de-escalation involves transitioning from broad-spectrum empiric therapy to targeted, narrow-spectrum therapy once a pathogen and its susceptibilities are confirmed.
Estimated Time:1m 15s
PreviousPage 147 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 147 | Examkin